Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Protalix BioTherapeutics (PLX) Property, Plant & Equipment (Gross) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Gross) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,131.28
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 41.93 Mn
Dec 31, 2025 41.93 Mn
Dec 31, 2024 40.33 Mn
Dec 31, 2024 40.33 Mn
Dec 31, 2023 39.66 Mn
Dec 31, 2023 39.66 Mn
Dec 31, 2022 38.24 Mn
Dec 31, 2022 38.24 Mn
Dec 31, 2021 37.71 Mn
Dec 31, 2021 37.71 Mn
Dec 31, 2020 36.77 Mn
Dec 31, 2020 36.77 Mn
Dec 31, 2019 35.98 Mn
Dec 31, 2019 35.98 Mn
Dec 31, 2018 35.51 Mn
Dec 31, 2018 35.51 Mn
Dec 31, 2017 35.14 Mn
Dec 31, 2017 35.14 Mn
Dec 31, 2016 34.30 Mn
Dec 31, 2016 34.30 Mn
Dec 31, 2015 33.55 Mn
Dec 31, 2015 33.55 Mn
Dec 31, 2014 32.74 Mn
Dec 31, 2014 32.74 Mn
Dec 31, 2013 32.03 Mn
Dec 31, 2013 32.03 Mn
Dec 31, 2012 31.10 Mn
Dec 31, 2012 31.10 Mn
Dec 31, 2011 29.42 Mn
Dec 31, 2011 29.42 Mn